Description
Betty Hamilton, MD, Associate Director of the Blood and Marrow Transplant (BMT) Program at Cleveland Clinic joins the Cancer Advances podcast to talk about managing chimeric antigen receptor (CAR) T-cell therapy and other novel cellular therapies within different cancer programs to support participation in and expansion of new clinical trials.
Audio
Featured in this Episode
No persons identified in this episode.
Transcription
No transcription available yet
Help us prioritize this episode for transcription by upvoting it.
0
upvotes
Popular episodes get transcribed faster